These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 8585293)

  • 1. Intranasal immunization of mice against influenza with synthetic peptides anchored to proteosomes.
    Levi R; Aboud-Pirak E; Leclerc C; Lowell GH; Arnon R
    Vaccine; 1995 Oct; 13(14):1353-9. PubMed ID: 8585293
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthetic recombinant influenza vaccine induces efficient long-term immunity and cross-strain protection.
    Levi R; Arnon R
    Vaccine; 1996 Jan; 14(1):85-92. PubMed ID: 8821654
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intranasal immunization with synthetic recombinant vaccine containing multiple epitopes of influenza virus.
    Jeon SH; Ben-Yedidia T; Arnon R
    Vaccine; 2002 Jun; 20(21-22):2772-80. PubMed ID: 12034104
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combination of M2e peptide with stalk HA epitopes of influenza A virus enhances protective properties of recombinant vaccine.
    Tsybalova LM; Stepanova LA; Shuklina MA; Mardanova ES; Kotlyarov RY; Potapchuk MV; Petrov SA; Blokhina EA; Ravin NV
    PLoS One; 2018; 13(8):e0201429. PubMed ID: 30138320
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Induction of systemic immune responses to measles virus synthetic peptides administered intranasally.
    Hathaway LJ; Partidos CD; Vohra P; Steward MW
    Vaccine; 1995 Nov; 13(16):1495-500. PubMed ID: 8578832
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intranasal Immunization with Influenza Virus-Like Particles Containing Membrane-Anchored Cholera Toxin B or Ricin Toxin B Enhances Adaptive Immune Responses and Protection against an Antigenically Distinct Virus.
    Ji X; Ren Z; Xu N; Meng L; Yu Z; Feng N; Sang X; Li S; Li Y; Wang T; Zhao Y; Wang H; Zheng X; Jin H; Li N; Yang S; Cao J; Liu W; Gao Y; Xia X
    Viruses; 2016 Apr; 8(4):115. PubMed ID: 27110810
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influenza A subtype cross-protection after immunization of outbred mice with a purified chimeric NS1/HA2 influenza virus protein.
    Mbawuike IN; Dillion SB; Demuth SG; Jones CS; Cate TR; Couch RB
    Vaccine; 1994 Nov; 12(14):1340-8. PubMed ID: 7856302
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Induction of measles virus-specific cytotoxic T-cell responses after intranasal immunization with synthetic peptides.
    Partidos CD; Vohra P; Steward MW
    Immunology; 1996 Feb; 87(2):179-85. PubMed ID: 8698377
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structural basis for the development of avian virus capsids that display influenza virus proteins and induce protective immunity.
    Pascual E; Mata CP; Gómez-Blanco J; Moreno N; Bárcena J; Blanco E; Rodríguez-Frandsen A; Nieto A; Carrascosa JL; Castón JR
    J Virol; 2015 Mar; 89(5):2563-74. PubMed ID: 25520499
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Peptide-based synthetic recombinant vaccines with anti-viral efficacy.
    Arnon R; Tarrab-Hazdai R; Ben-Yedidia T
    Biologicals; 2001; 29(3-4):237-42. PubMed ID: 11851322
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In contrast to conventional inactivated influenza vaccines, 4xM2e.HSP70c fusion protein fully protected mice against lethal dose of H1, H3 and H9 influenza A isolates circulating in Iran.
    Ebrahimi SM; Dabaghian M; Tebianian M; Jazi MH
    Virology; 2012 Aug; 430(1):63-72. PubMed ID: 22595444
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intranasal administration of a synthetic peptide vaccine encapsulated in liposome together with an anti-CD40 antibody induces protective immunity against influenza A virus in mice.
    Ninomiya A; Ogasawara K; Kajino K; Takada A; Kida H
    Vaccine; 2002 Aug; 20(25-26):3123-9. PubMed ID: 12163263
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of pre-existing carrier immunity on the efficacy of synthetic influenza vaccine.
    Ben-Yedidia T; Arnon R
    Immunol Lett; 1998 Nov; 64(1):9-15. PubMed ID: 9865596
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intranasal delivery of adjuvant-free peptide nanofibers elicits resident CD8
    Si Y; Wen Y; Kelly SH; Chong AS; Collier JH
    J Control Release; 2018 Jul; 282():120-130. PubMed ID: 29673645
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Induction of humoral and cellular immunity against influenza virus by immunization of newborn mice with a plasmid bearing a hemagglutinin gene.
    Bot A; Antohi S; Bot S; Garcia-Sastre A; Bona C
    Int Immunol; 1997 Nov; 9(11):1641-50. PubMed ID: 9418125
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protection against multiple influenza A virus strains induced by candidate recombinant vaccine based on heterologous M2e peptides linked to flagellin.
    Stepanova LA; Kotlyarov RY; Kovaleva AA; Potapchuk MV; Korotkov AV; Sergeeva MV; Kasianenko MA; Kuprianov VV; Ravin NV; Tsybalova LM; Skryabin KG; Kiselev OI
    PLoS One; 2015; 10(3):e0119520. PubMed ID: 25799221
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthetic recombinant vaccine expressing influenza haemagglutinin epitope in Salmonella flagellin leads to partial protection in mice.
    McEwen J; Levi R; Horwitz RJ; Arnon R
    Vaccine; 1992; 10(6):405-11. PubMed ID: 1376012
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protection of mice against lethal viral infection by synthetic peptides corresponding to B- and T-cell recognition sites of influenza A hemagglutinin.
    Simeckova-Rosenberg J; Yun Z; Wyde PR; Atassi MZ
    Vaccine; 1995 Jul; 13(10):927-32. PubMed ID: 7483766
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acceleration of influenza virus clearance by Th1 cells in the nasal site of mice immunized intranasally with adjuvant-combined recombinant nucleoprotein.
    Tamura S; Miyata K; Matsuo K; Asanuma H; Takahashi H; Nakajima K; Suzuki Y; Aizawa C; Kurata T
    J Immunol; 1996 May; 156(10):3892-900. PubMed ID: 8621928
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intranasal Epitope-Polymer Vaccine Lodges Resident Memory T Cells Protecting Against Influenza Virus.
    Liu Z; Kabir MT; Chen S; Zhang H; Wakim LM; Rehm BHA
    Adv Healthc Mater; 2024 Jun; 13(15):e2304188. PubMed ID: 38411375
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.